Zoetis

Zoetis is a global leader in animal health, headquartered in Parsippany, New Jersey. The company began as Pfizer’s animal health division and became independent in 2013. Zoetis develops, manufactures, and markets vaccines, medicines, diagnostics, digital tools, and genetic tests for livestock and companion animals across more than 100 countries. Its product portfolio covers parasiticides, anti-infectives, vaccines, and diagnostic devices for pets and livestock. Zoetis integrates research, production, and distribution, owning a network of over 25 manufacturing sites globally. In the second quarter of 2025, Zoetis reported revenue of $2.4 billion, marking 6% year-over-year growth, primarily driven by strong demand in pet parasiticides and companion animal vaccines. The company maintains robust regulatory compliance with FDA and EMA standards and pursues long-term sustainability under its Driven to Care" ESG framework. Zoetis’ innovation strategy emphasizes digital veterinary solutions and precision livestock health to strengthen its global market leadership."